New stock news | Robotechnik Intelligent Technology (300757.SZ) submits application to Hong Kong Stock Exchange again.

06:26 14/05/2026

According to the disclosure of the Hong Kong Stock Exchange on May 13, Roborock Intelligent Technology Co., Ltd. (referred to as Roborock Technology, 300757.SZ) once again submitted its listing application to the Main Board of the Hong Kong Stock Exchange, with Huatai International, Citigroup, and Orient Securities International as joint sponsors.

According to the disclosure on May 13th by the Hong Kong Stock Exchange, Robotechnik Intelligent Technology Co., Ltd. (referred to as: Robotechnik Intelligent Technology, 300757.SZ) has once again submitted an application for listing on the mainboard of the Hong Kong Stock Exchange, with Huatai International, Citi and Orient International as joint sponsors. The company is a global leading supplier of high-precision intelligent manufacturing equipment and systems. According to data from Zhuoshi Consulting, based on revenue in 2024, the company ranks first in the global silicon photonics intelligent manufacturing equipment market.

BeOne Medicines Ltd. (06160): Baiyueda has been approved by the US FDA to become the first and currently the only BCL2 inhibitor for the treatment of relapsed/refractory mantle cell lymphoma in the United States.

DISTINCT HEALTH (02677) adopts the 2026 stock incentive plan.

Distinct Health (02677) recorded a total revenue of approximately 2.8-2.9 billion yuan in the first quarter, representing a year-on-year growth of 12% to 16%.

DISTINCT HEALTH (02677) adopts the 2026 stock incentive plan.

Distinct Health (02677) recorded a total revenue of approximately 2.8-2.9 billion yuan in the first quarter, representing a year-on-year growth of 12% to 16%.